Skip to main content
GILD
NASDAQ Life Sciences

Gilead Sciences Finalizes Arcellx Acquisition, Paving Way for Anito-cel Launch

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$129
Mkt Cap
$158.566B
52W Low
$93.37
52W High
$157.29
52W Position info
38% above low
Off High info
18% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

GILD sits 38% above its 52-week low of $93.37.

Summary

Gilead Sciences has officially completed its acquisition of Arcellx. This finalizes a significant strategic move, following the announcement on April 17 that Gilead had secured all necessary regulatory approvals for the deal. The acquisition, which was detailed in Gilead's recent 10-K as a $7.0 billion transaction, is material for the company, solidifying its expansion into cell therapy. The completion secures Gilead's rights to Anito-cel, a promising candidate, and the focus now shifts to the integration of Arcellx and the potential commercial launch of this product, which could be a significant future growth driver.

At the time of this announcement, GILD was trading at $129.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $158.6B. The 52-week trading range was $93.37 to $157.29. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

GILD - Latest Insights

GILD
Nov 06, 2026, 12:16 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $167.82
Real-time Price: $169.00 info
Change: +$1.19 (+0.71%) info
Market Cap: $209.592B info
GILD
Nov 05, 2026, 10:35 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $174.57
Real-time Price: $169.00 info
Change: -$5.56 (-3%) info
Market Cap: $209.592B info
GILD
Oct 29, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $165.88
Real-time Price: $169.00 info
Change: +$3.12 (+2%) info
Market Cap: $209.592B info
GILD
Oct 29, 2026, 4:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $164.00
Real-time Price: $169.00 info
Change: +$5.00 (+3%) info
Market Cap: $209.592B info
GILD
Oct 22, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $157.19
Real-time Price: $169.00 info
Change: +$11.81 (+8%) info
Market Cap: $209.592B info